biotechnology
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Infographic: Writing with DNA
Infographic: Writing with DNA
Catherine Offord | Sep 30, 2017
Researchers devise numerous strategies to encode information into nucleic acids.
Synthetic Genomics Faces Gender Discrimination Suit
Synthetic Genomics Faces Gender Discrimination Suit
Ashley P. Taylor | Sep 21, 2017
A former employee alleges that J. Craig Venter and others at his company treated women unfairly.
Organs on Chips
Organs on Chips
Diana Kwon | Aug 28, 2017
Scientists hope that these devices will one day replace animal models of disease and help advance personalized medicine.
Custom-Made Molecules
Custom-Made Molecules
Ruth Williams | Aug 21, 2017
A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.
Thermo Fisher to Buy Patheon for $5.2 Billion
Thermo Fisher to Buy Patheon for $5.2 Billion
Aggie Mika | May 16, 2017
The scientific supply giant seeks to expand into biopharma development and manufacturing.  
Former Head of Genzyme Dies
Former Head of Genzyme Dies
Diana Kwon | May 15, 2017
Henri Termeer helped usher the biotech company into an industry behemoth.
Mini Female Reproductive System on a Chip
Mini Female Reproductive System on a Chip
Diana Kwon | Mar 28, 2017
Scientists create an organ-on-a-chip system that can simulate the human menstrual cycle. 
Image of the Day: Electronic Beats
Image of the Day: Electronic Beats
The Scientist Staff | Feb 26, 2017
Scientists create an artificial heart fiber that can mimic the movement in a living heart.
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.